Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bouchet

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Le Poumon Et Le Coeur|May 1, 1980
[Pancoast and Tobias syndrome of benign etiology (author's transl)]M Aubert, A Perdrix, C Bouchet, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|March 1, 1997
[The DUKE health profile: a generic instrument to measure the quality of life tied to health]F Guillemin, A Paul-Dauphin, J M Virion, et al.
British Journal of Cancer|July 4, 1998
Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methodsC Bouchet, F Spyratos, K Hacène, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 15, 1980
[Septicemia following infection of an endocardial electrode lead (author's transl)]M Aubert, J Pellet, C Roche, et al.
Intensive Care Medicine|September 16, 2000
Parenteral with enteral nutrition in the critically illP Bauer, C Charpentier, C Bouchet, et al.
Journal Des Maladies Vasculaires|January 1, 1983
[Axillary-subclavian injuries. Apropos of 11 cases. Procedural problems]J L Magne, P Y Meaulle, C Bouchet, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Leveen peritoneo-jugular shunt. Results of our own experience apropos of 35 cases]J L Magne, C Bouchet, J P Zarski, et al.
Breast Cancer Research and Treatment|January 1, 1996
Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissuesC Bouchet-Bernet, F Spyratos, C Andrieu, et al.
Bulletin Du Cancer|September 1, 1994
[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer]C Bouchet, F Spyratos, P M Martin, et al.
British Journal of Cancer|February 1, 1994
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasC Bouchet, F Spyratos, P M Martin, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Le Poumon Et Le Coeur|May 1, 1980
[Pancoast and Tobias syndrome of benign etiology (author's transl)]M Aubert, A Perdrix, C Bouchet, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|March 1, 1997
[The DUKE health profile: a generic instrument to measure the quality of life tied to health]F Guillemin, A Paul-Dauphin, J M Virion, et al.
British Journal of Cancer|July 4, 1998
Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methodsC Bouchet, F Spyratos, K Hacène, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 15, 1980
[Septicemia following infection of an endocardial electrode lead (author's transl)]M Aubert, J Pellet, C Roche, et al.
Intensive Care Medicine|September 16, 2000
Parenteral with enteral nutrition in the critically illP Bauer, C Charpentier, C Bouchet, et al.
Journal Des Maladies Vasculaires|January 1, 1983
[Axillary-subclavian injuries. Apropos of 11 cases. Procedural problems]J L Magne, P Y Meaulle, C Bouchet, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1984
[Leveen peritoneo-jugular shunt. Results of our own experience apropos of 35 cases]J L Magne, C Bouchet, J P Zarski, et al.
Breast Cancer Research and Treatment|January 1, 1996
Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissuesC Bouchet-Bernet, F Spyratos, C Andrieu, et al.
Bulletin Du Cancer|September 1, 1994
[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer]C Bouchet, F Spyratos, P M Martin, et al.
British Journal of Cancer|February 1, 1994
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasC Bouchet, F Spyratos, P M Martin, et al.
Pageof 8